New device study for ICU drug delivery
This trial tests a new medical device that gives medication to patients in the intensive care unit (ICU). It aims to see if the device works safely and effectively.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently in the intensive care unit (ICU).
- You or your legal representative can sign a consent form agreeing to take part.
- You do not have a bleeding disorder like hemophilia or a condition that affects how your blood clots.
- You do not have an active infection at the device placement site or a serious body-wide infection.
- You are able to understand and agree to participate in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how to make central lines safer by testing different ways to secure them and what caps to use. It is for people who need a central line, including those with cancer, and focuses on preventing infections.
This study looks at ways to lower complications from a type of IV line called a PICC, which is used for long-term treatments. You may qualify if you are independent in your daily activities and can manage your own care.
This trial tests a new device that measures heart function closely after heart surgery. It may help doctors give better care if you are in the heart intensive care unit after your operation.
This trial tests a new device that measures antibiotic levels in blood quickly at the bedside, so doctors can adjust your dose to make sure it's effective. It may help ICU patients on beta-lactam antibiotics get the right amount.
This trial tests a device or method to make IV infusions safer for patients who need fluids or medications through a tube in a vein. It's for adults who already have or will get an IV line for treatments lasting at least 15 minutes.
This trial tests a wearable ultrasound sensor that can be stuck to the skin to monitor your heart, leg blood clots, or vital signs in the ICU. It may replace bulky machines and let doctors see your condition more easily and continuously.
Hear when a new Vascular Access trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.